Intravenous administration of beta-carboline-3-carboxylate methyl ester (beta-CCM) produced convulsions at small doses (0.03 mg/kg) in adult chickens, homozygous for the epileptic gene. Nonepileptic heterozygote hatchmates (carriers) did not undergo seizures at doses of 1 mg/kg, and doses of 3-5 mg/kg produced only brief myoclonic responses. The convulsant effect of beta-CCM could be prevented by pretreatment with large doses of beta-carboline-3-carboxylate propyl ester (beta-CCP). beta-Carboline-3-carboxylate methyl ester displayed a higher affinity than diazepam in displacement studies on synaptosomal membrane preparations from brains of epileptic and carrier chickens.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0028-3908(84)90122-9DOI Listing

Publication Analysis

Top Keywords

beta-carboline-3-carboxylate methyl
8
methyl ester
8
pharmacology methyl-
4
methyl- propyl-beta-carbolines
4
propyl-beta-carbolines hereditary
4
hereditary model
4
model epilepsy
4
epilepsy intravenous
4
intravenous administration
4
administration beta-carboline-3-carboxylate
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!